Varizig 125 Unit

Varicella Zoster Immunoglobulin (Human) is a solution used to prevent varicella (chickenpox) in high-risk individuals. This 125 unit intramuscular injection is manufactured by KI Biopharma LLC in the United States.

Varicella Zoster Immunoglobulin (Human) is primarily used for post-exposure prophylaxis against varicella in individuals who are at high risk of severe complications. This includes immunocompromised individuals, newborns of mothers with varicella, and pregnant women. The solution is administered intramuscularly to provide passive immunity against the varicella-zoster virus.

Common effects of Varicella Zoster Immunoglobulin (Human) may include mild soreness or redness at the injection site. Some individuals might experience temporary discomfort or swelling. These effects are generally mild and resolve quickly.

Varicella Zoster Immunoglobulin (Human) should be handled with care and stored as per the manufacturer's instructions. It is important to inform healthcare providers of any known allergies or medical conditions before administration. Always follow proper injection techniques to minimize the risk of infection or adverse reactions.

Varicella Zoster Immunoglobulin (Human) may interact with other medications or immunizations. It is advisable to consult with a healthcare provider before using this product alongside other treatments. Avoid using this product if you have a known allergy to any of its components.